Sugiyama Daisuke
(杉山 大介)
Modified on: 02/01
Profile Information
Research Areas
1Papers
32-
Scientific reports, 13(1) 5939-5939, Apr 12, 2023
-
Cancer science, 114(3) 730-740, Mar, 2023
-
Experimental Dermatology, 32(3) 256-263, Dec 12, 2022
-
Life sciences, 308 120955-120955, Nov 1, 2022
-
Life science alliance, 5(6), Jun, 2022
-
Cancer cell, 40(2) 201-218, Feb 14, 2022
-
Nature communications, 12(1) 7280-7280, Dec 14, 2021
-
Cancers, 13(23) 5904-5904, Nov 24, 2021 Peer-reviewed
-
International Immunology, 33(8) 435-446, Jul 23, 2021
-
Science Translational Medicine, 13(593) eabb7495, May 12, 2021 Peer-reviewed
-
JCI Insight, 6(9), May 10, 2021
-
International journal of hematology, 113(5) 772-774, Feb 8, 2021
-
International journal of hematology, 113(4) 473-479, Jan 28, 2021
-
International immunology, 33(1) 39-48, Jan 1, 2021
-
Inflammatory bowel diseases, 26(11) 1669-1681, Oct 23, 2020
-
International immunology, 32(4) 273-281, Apr 12, 2020
-
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.The Journal of experimental medicine, 217(2), Feb 3, 2020
-
The Journal of experimental medicine, 216(12) 2701-2713, Dec 2, 2019
-
Clinical cancer research : an official journal of the American Association for Cancer Research, 25(15) 4808-4819, Aug 1, 2019
Misc.
6-
日本リンパ網内系学会会誌, 58 109-109, May 31, 2018
-
17(1) 94-97, Jan, 2016
-
日本癌学会総会記事, 73回 J-1103, Sep, 2014
-
日本がん免疫学会総会プログラム・抄録集, 17回 98-98, Jul, 2013
-
244(9) 800-807, Mar 2, 2013
Research Projects
3-
科学研究費助成事業, 若手研究, 日本学術振興会, Apr, 2022 - Mar, 2025
-
Grants-in-Aid for Scientific Research, Grant-in-Aid for Early-Career Scientists, Japan Society for the Promotion of Science, Apr, 2019 - Mar, 2022
-
Grants-in-Aid for Scientific Research Grant-in-Aid for Research Activity Start-up, Grant-in-Aid for Research Activity Start-up, Japan Society for the Promotion of Science, Aug, 2015 - Mar, 2017